Analyst Reco. Aveanna Healthcare Holdings Inc.

Equities

AVAH

US05356F1057

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
2.92 ^USD	+0.34%		+13.62%	+8.96%

May. 13	UBS Adjusts Aveanna Healthcare Price Target to $1.70 From $1.60, Maintains Sell Rating	MT
May. 09	Transcript : Aveanna Healthcare Holdings Inc., Q1 2024 Earnings Call, May 09, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UBS Adjusts Aveanna Healthcare Price Target to $1.70 From $1.60, Maintains Sell Rating	May. 13	MT
Deutsche Bank Adjusts Aveanna Healthcare Price Target to $3 From $2, Maintains Buy Rating	Mar. 18	MT
JPMorgan Downgrades Aveanna Healthcare to Underweight From Neutral	Dec. 13	MT
UBS Initiates Coverage on Aveanna Healthcare With Sell Rating, $1.50 Price Target	Nov. 30	MT
Deutsche Bank Adjusts Aveanna Healthcare Price Target to $2 From $1.70, Maintains Buy Rating	23-08-14	MT
RBC Boosts Price Target on Aveanna Healthcare Holdings to $3 From $2 After 'Solid' Q2 Results, Keeps Sector Perform Rating	23-08-14	MT
Truist Securities Adjusts Aveanna Healthcare Price Target to $1.70 From $1.40, Maintains Hold Rating	23-07-13	MT
Raymond James Downgrades Aveanna Healthcare Holdings to Market Perform From Strong Buy	23-05-12	MT
Aveanna Healthcare Receives Price Target Cut to $2 From $3 From RBC as 2023 EBITDA View Disappoints; Sector Perform Kept	23-03-20	MT
Raymond James Adjusts Price Target on Aveanna Healthcare to $3 From $4, Keeps Strong Buy Rating	23-03-20	MT
Truist Securities Adjusts Price Target on Aveanna Healthcare Holdings to $1.40 From $1, Maintains Hold Rating	23-03-17	MT
Deutsche Bank Lowers Price Target on Aveanna Healthcare to $1.70 From $3, Keeps Buy Rating	23-03-17	MT
Credit Suisse Downgrades Aveanna Healthcare Holdings to Underperform From Neutral, Notes High Leverage, Uncertain Timing of Turnaround; Trims PT to $1 From $2	23-01-27	MT
RBC Capital Downgrades Aveanna Healthcare Holdings to Sector Perform From Outperform, Adjusts Price Target to $3 From $7	22-11-21	MT
Credit Suisse Downgrades Aveanna Healthcare Holdings to Neutral From Outperform Given Debt Levels, Cuts PT to $2 From $5.50	22-11-17	MT
Raymond James Adjusts Price Target on Aveanna Healthcare Holdings to $4 From $6, Maintains Strong Buy Rating	22-11-16	MT
Stephens Adjusts Price Target on Aveanna Healthcare Holdings to $1.50 From $2.25, Maintains Equal-Weight Rating	22-11-11	MT
Barclays Adjusts Price Target on Aveanna Healthcare Holdings to $5 From $7, Reiterates Overweight Rating	22-08-19	MT
Raymond James Adjusts Price Target on Aveanna Healthcare Holdings to $6 From $8, Reiterates Strong Buy Rating	22-08-15	MT
Deutsche Bank Adjusts Price Target on Aveanna Healthcare Holdings to $3 From $6, Maintains Buy Rating	22-08-12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Aveanna Healthcare Holdings Inc.

Equities

AVAH

US05356F1057

Analyst Reco.

Filters